Literature DB >> 1672447

Clinical and molecular genetic study of a large German kindred with Gerstmann-Sträussler-Scheinker syndrome.

P Brown1, L G Goldfarb, W T Brown, D Goldgaber, R Rubenstein, R J Kascsak, D C Guiroy, P Piccardo, J W Boellaard, D C Gajdusek.   

Abstract

We have verified, by full open reading frame sequencing, the presence of an amino-acid-altering mutation in codon 102 of the scrapie amyloid protein gene in three affected members of a large and well-documented German family with experimentally transmitted Gerstmann-Sträussler-Scheinker syndrome. In addition, we identified the mutation by partial sequencing or DNA restriction enzyme analysis in three of 12 presently healthy family members with an affected parent, and none of 12 members without an affected parent. Thus, a total of six of 15 family members at risk for the disease (including the three established cases) had the same codon 102 mutation, a proportion consistent with the autosomal dominant inheritance pattern of disease expression. It is undetermined whether the mutation influences susceptibility to infection by an exogenous agent or is itself a proximate cause of disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672447     DOI: 10.1212/wnl.41.3.375

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  PrP amyloid plaques in Creutzfeldt-Jakob disease of short duration: immunohistochemical studies of 5 cases from Poland.

Authors:  P P Liberski; H Kwiecinski; M Barcikowska; B Mirecka; J Kulczycki; E Kida; P Brown; D C Gajdusek
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

Review 2.  Creutzfeldt-Jakob disease among Libyan Jews.

Authors:  A D Korczyn
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

3.  Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies.

Authors:  M Haltia; J Kovanen; L G Goldfarb; P Brown; D C Gajdusek
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

4.  The phenotypic expression of different mutations in transmissible familial Creutzfeldt-Jakob disease.

Authors:  P Brown; L G Goldfarb; C J Gibbs; D C Gajdusek
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

5.  Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene.

Authors:  L G Goldfarb; P Brown; W R McCombie; D Goldgaber; G D Swergold; P R Wills; L Cervenakova; H Baron; C J Gibbs; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 6.  Prions, beta-sheets and transmissible dementias: is there still something missing?

Authors:  P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Miniplaques and shapeless cerebral amyloid deposits in a case of Gerstmann-Sträussler-Scheinker's syndrome.

Authors:  J W Boellaard; J Doerr-Schott; W Schlote
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  A Japanese family with a variant of Gerstmann-Sträussler-Scheinker disease.

Authors:  Y Tanaka; K Minematsu; H Moriyasu; T Yamaguchi; C Yutani; T Kitamoto; H Furukawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

9.  Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred.

Authors:  G Giaccone; L Verga; O Bugiani; B Frangione; D Serban; S B Prusiner; M R Farlow; B Ghetti; F Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.

Authors:  P Parchi; S G Chen; P Brown; W Zou; S Capellari; H Budka; J Hainfellner; P F Reyes; G T Golden; J J Hauw; D C Gajdusek; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.